Immunoglobulins in adult sepsis and septic shock (Q38034107)

27 August 2017

Immunoglobulins in adult sepsis and septic shock (English)

1 reference

27 August 2017

0 references

1 reference

Susanne Toussaint

1

1 reference

PubMed ID

22886554

27 August 2017

Herwig Gerlach

series ordinal

2

1 reference

PubMed ID

22886554

27 August 2017

language of work or name

1 reference

1 October 2012

1 reference

Current infectious disease reports

27 August 2017

1 reference

27 August 2017

14

1 reference

27 August 2017

5

1 reference

27 August 2017

522-529

1 reference

27 August 2017

Organ failure in sepsis

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Epidemiology of sepsis in Germany: results from a national prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Manipulating the Immune System with Immune Globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Intravenous immunoglobulins--understanding properties and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Passively administered pooled human immunoglobulins exert IL-10 dependent anti-inflammatory effects that protect against fatal HSV encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Ambivalent effect of immunoglobulins on the complement system: activation versus inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Clinical applications of intravenous immunoglobulins (IVIg)--beyond immunodeficiencies and neurology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Clinical uses of intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Pepsin-Treated Human Gamma Globulin in Bacterial Infections: A Randomized Study in Patients with Septicaemia and Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Multicenter evaluation of a human monoclonal antibody to Enterobacteriaceae common antigen in patients with Gram-negative sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Potential Treatment of Sepsis Syndrome with Cytokine-Specific Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Immunologic therapy for ARDS, septic shock, and multiple-organ failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Intravenous immunoglobulin in children with streptococcal toxic shock syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Assessing the impact of intravenous immunoglobulin in the management of streptococcal toxic shock syndrome: a noble but difficult quest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Clinical trials of immunomodulatory therapies in severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

New treatment approaches in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Polyclonal intravenous immunoglobulin for the prophylaxis and treatment of infection in critically ill adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Intravenous immunoglobulin for treating sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Treatment of septic thrombocytopenia with immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Inclusion criteria for clinical trials in sepsis: did the American College of Chest Physicians/Society of Critical Care Medicine consensus conference definitions of sepsis have an impact?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

Treatment of Neonatal Sepsis with Intravenous Immune Globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0287-Z

How important is publication bias? A synthesis of available data.

21 January 2018

1 reference

12 December 2020

Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy

1 reference

12 December 2020

Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group

1 reference

12 December 2020

IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial

1 reference

12 December 2020

Monoclonal antibodies to endotoxin in the management of sepsis.

1 reference

12 December 2020

Intravenous administration of immunoglobulins in young children with staphylococcal infections

1 reference

12 December 2020

Rationale for the use of intravenous gamma globulin in the treatment of streptococcal toxic shock syndrome

1 reference

12 December 2020

The gamma globulins and their clinical significance. II. Hypogammaglobulinemia

1 reference

12 December 2020

Meta-analysis: Intravenous Immunoglobulin in Critically Ill Adult Patients with Sepsis

1 reference

12 December 2020

Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study

1 reference

12 December 2020

Agammaglobulinemia, congenital, acquired and transient forms

1 reference

12 December 2020

Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials

1 reference

12 December 2020

High-dose intravenous gammaglobulin therapy of refractory, in particular idiopathic thrombocytopenia in childhood

1 reference

12 December 2020

Different Preparations of Intravenous Immunoglobulin Vary in Their Efficacy to Neutralize Streptococcal Superantigens: Implications for Treatment of Streptococcal Toxic Shock Syndrome

1 reference

12 December 2020

Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study

1 reference

12 December 2020

Polyclonal intravenous immune globulin for prevention and treatment of infections in critically ill patients

1 reference

12 December 2020

Polyvalent immunoglobulins for prophylaxis of bacterial infections in patients following multiple trauma. A randomized, placebo-controlled study

1 reference

12 December 2020

Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial.

1 reference

12 December 2020

Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients.

1 reference

12 December 2020

10.1007/S11908-012-0287-Z

Identifiers

DOI

1 reference

27 August 2017

1 reference

PubMed ID

22886554